Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Authors: Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston., Yau C; Department of Surgery, University of California, San Francisco., Chen YY; Department of Pathology, University of California, San Francisco., Balassanian R; Department of Pathology, University of California, San Francisco., Klein ME; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis., Pusztai L; Department of Medicine, Medical Oncology, Yale University, New Haven, Connecticut., Nanda R; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois., Parker BA; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla., Datnow B; Department of Pathology, University of California, San Diego, La Jolla., Krings G; Department of Pathology, University of California, San Francisco., Wei S; Department of Anatomic Pathology, University of Alabama at Birmingham., Feldman MD; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia., Duan X; Department of Pathology, Loyola University, Chicago, Illinois., Chen B; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Sattar H; Department of Pathology, University of Chicago, Chicago, Illinois., Khazai L; Department of Pathology, Moffitt Cancer Center, Tampa, Florida., Zeck JC; Department of Pathology, Georgetown University, Washington, DC., Sams S; Department of Pathology, University of Colorado Anschutz Medical Center, Aurora., Mhawech-Fauceglia P; Department of Pathology, University of Southern California, Los Angeles., Rendi M; Department of Anatomic Pathology, University of Washington, Seattle., Sahoo S; Department of Pathology, University of Texas Southwestern, Dallas., Ocal IT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona., Fan F; Department of Pathology, University of Kansas Medical Center, Kansas City., LeBeau LG; Department of Pathology, University of Arizona Health Sciences, Tucson., Vinh T; Department of Pathology, Inova Health System, Fairfax, Virginia., Troxell ML; Department of Pathology, Oregon Health and Science University, Portland., Chien AJ; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco., Wallace AM; Department of Surgery, University of California, San Diego, La Jolla., Forero-Torres A; Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham., Ellis E; Medical Oncology, Swedish Cancer Institute, Seattle, Washington., Albain KS; Division of Hematology-Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois., Murthy RK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Boughey JC; Department of Surgery, Mayo Clinic, Rochester, Minnesota., Liu MC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Haley BB; Division of Hematology-Oncology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas., Elias AD; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora., Clark AS; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia., Kemmer K; Division of Hematology-Oncology, Department of Medicine, Oregon Health & Science University, Portland., Isaacs C; Division of Hematology-Oncology, Department of Medicine, Georgetown University, Washington, DC., Lang JE; Department of Surgery, University of Southern California, Los Angeles., Han HS; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida., Edmiston K; Department of Surgery, Inova Schar Cancer Institute, Fairfax, Virginia., Viscusi RK; Department of Surgery, University of Arizona Health Sciences, Tucson, Arizona., Northfelt DW; Department of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona., Khan QJ; Division of Oncology, Department of Medicine, University of Kansas, Kansas City., Leyland-Jones B; Medical Oncology, Avera Cancer Institute, Sioux Falls, South Dakota., Venters SJ; Department of Laboratory Medicine, University of California, San Francisco., Shad S; Department of Surgery, University of California, San Francisco., Matthews JB; Department of Surgery, University of California, San Francisco., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Buxton M; Berry Consultants, LLC, Houston, Texas., Asare AL; Quantum Leap Healthcare Collaborative, San Francisco, California., Rugo HS; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco., Schwab RB; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla., Helsten T; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla., Hylton NM; Department of Radiology and Biomedical Imaging, University of California, San Francisco., van 't Veer L; Department of Laboratory Medicine, University of California, San Francisco., Perlmutter J; Gemini Group, Ann Arbor, Michigan., DeMichele AM; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia., Yee D; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis., Berry DA; Berry Consultants, LLC, Houston, Texas., Esserman LJ; Department of Surgery, University of California, San Francisco.
Source: JAMA oncology [JAMA Oncol] 2021 Nov 01; Vol. 7 (11), pp. 1654-1663.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34529000
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Chen+YY%22">Chen YY</searchLink>; Department of Pathology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Balassanian+R%22">Balassanian R</searchLink>; Department of Pathology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Klein+ME%22">Klein ME</searchLink>; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.<br /><searchLink fieldCode="AU" term="%22Pusztai+L%22">Pusztai L</searchLink>; Department of Medicine, Medical Oncology, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Parker+BA%22">Parker BA</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla.<br /><searchLink fieldCode="AU" term="%22Datnow+B%22">Datnow B</searchLink>; Department of Pathology, University of California, San Diego, La Jolla.<br /><searchLink fieldCode="AU" term="%22Krings+G%22">Krings G</searchLink>; Department of Pathology, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Wei+S%22">Wei S</searchLink>; Department of Anatomic Pathology, University of Alabama at Birmingham.<br /><searchLink fieldCode="AU" term="%22Feldman+MD%22">Feldman MD</searchLink>; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Duan+X%22">Duan X</searchLink>; Department of Pathology, Loyola University, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Chen+B%22">Chen B</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Sattar+H%22">Sattar H</searchLink>; Department of Pathology, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Khazai+L%22">Khazai L</searchLink>; Department of Pathology, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Zeck+JC%22">Zeck JC</searchLink>; Department of Pathology, Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Sams+S%22">Sams S</searchLink>; Department of Pathology, University of Colorado Anschutz Medical Center, Aurora.<br /><searchLink fieldCode="AU" term="%22Mhawech-Fauceglia+P%22">Mhawech-Fauceglia P</searchLink>; Department of Pathology, University of Southern California, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Rendi+M%22">Rendi M</searchLink>; Department of Anatomic Pathology, University of Washington, Seattle.<br /><searchLink fieldCode="AU" term="%22Sahoo+S%22">Sahoo S</searchLink>; Department of Pathology, University of Texas Southwestern, Dallas.<br /><searchLink fieldCode="AU" term="%22Ocal+IT%22">Ocal IT</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Fan+F%22">Fan F</searchLink>; Department of Pathology, University of Kansas Medical Center, Kansas City.<br /><searchLink fieldCode="AU" term="%22LeBeau+LG%22">LeBeau LG</searchLink>; Department of Pathology, University of Arizona Health Sciences, Tucson.<br /><searchLink fieldCode="AU" term="%22Vinh+T%22">Vinh T</searchLink>; Department of Pathology, Inova Health System, Fairfax, Virginia.<br /><searchLink fieldCode="AU" term="%22Troxell+ML%22">Troxell ML</searchLink>; Department of Pathology, Oregon Health and Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Chien+AJ%22">Chien AJ</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Wallace+AM%22">Wallace AM</searchLink>; Department of Surgery, University of California, San Diego, La Jolla.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham.<br /><searchLink fieldCode="AU" term="%22Ellis+E%22">Ellis E</searchLink>; Medical Oncology, Swedish Cancer Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Division of Hematology-Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Murthy+RK%22">Murthy RK</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Department of Surgery, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Haley+BB%22">Haley BB</searchLink>; Division of Hematology-Oncology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Elias+AD%22">Elias AD</searchLink>; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora.<br /><searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Kemmer+K%22">Kemmer K</searchLink>; Division of Hematology-Oncology, Department of Medicine, Oregon Health & Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Division of Hematology-Oncology, Department of Medicine, Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Lang+JE%22">Lang JE</searchLink>; Department of Surgery, University of Southern California, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Han+HS%22">Han HS</searchLink>; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Edmiston+K%22">Edmiston K</searchLink>; Department of Surgery, Inova Schar Cancer Institute, Fairfax, Virginia.<br /><searchLink fieldCode="AU" term="%22Viscusi+RK%22">Viscusi RK</searchLink>; Department of Surgery, University of Arizona Health Sciences, Tucson, Arizona.<br /><searchLink fieldCode="AU" term="%22Northfelt+DW%22">Northfelt DW</searchLink>; Department of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Khan+QJ%22">Khan QJ</searchLink>; Division of Oncology, Department of Medicine, University of Kansas, Kansas City.<br /><searchLink fieldCode="AU" term="%22Leyland-Jones+B%22">Leyland-Jones B</searchLink>; Medical Oncology, Avera Cancer Institute, Sioux Falls, South Dakota.<br /><searchLink fieldCode="AU" term="%22Venters+SJ%22">Venters SJ</searchLink>; Department of Laboratory Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Shad+S%22">Shad S</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; Department of Surgery, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Asare+SM%22">Asare SM</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Buxton+M%22">Buxton M</searchLink>; Berry Consultants, LLC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Asare+AL%22">Asare AL</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Schwab+RB%22">Schwab RB</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla.<br /><searchLink fieldCode="AU" term="%22Helsten+T%22">Helsten T</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; Department of Radiology and Biomedical Imaging, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+L%22">van 't Veer L</searchLink>; Department of Laboratory Medicine, University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, LLC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; Department of Surgery, University of California, San Francisco.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2021 Nov 01; Vol. 7 (11), pp. 1654-1663.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34529000
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2021.3690
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1654
    Titles:
      – TitleFull: Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Chen YY
      – PersonEntity:
          Name:
            NameFull: Balassanian R
      – PersonEntity:
          Name:
            NameFull: Klein ME
      – PersonEntity:
          Name:
            NameFull: Pusztai L
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Parker BA
      – PersonEntity:
          Name:
            NameFull: Datnow B
      – PersonEntity:
          Name:
            NameFull: Krings G
      – PersonEntity:
          Name:
            NameFull: Wei S
      – PersonEntity:
          Name:
            NameFull: Feldman MD
      – PersonEntity:
          Name:
            NameFull: Duan X
      – PersonEntity:
          Name:
            NameFull: Chen B
      – PersonEntity:
          Name:
            NameFull: Sattar H
      – PersonEntity:
          Name:
            NameFull: Khazai L
      – PersonEntity:
          Name:
            NameFull: Zeck JC
      – PersonEntity:
          Name:
            NameFull: Sams S
      – PersonEntity:
          Name:
            NameFull: Mhawech-Fauceglia P
      – PersonEntity:
          Name:
            NameFull: Rendi M
      – PersonEntity:
          Name:
            NameFull: Sahoo S
      – PersonEntity:
          Name:
            NameFull: Ocal IT
      – PersonEntity:
          Name:
            NameFull: Fan F
      – PersonEntity:
          Name:
            NameFull: LeBeau LG
      – PersonEntity:
          Name:
            NameFull: Vinh T
      – PersonEntity:
          Name:
            NameFull: Troxell ML
      – PersonEntity:
          Name:
            NameFull: Chien AJ
      – PersonEntity:
          Name:
            NameFull: Wallace AM
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Ellis E
      – PersonEntity:
          Name:
            NameFull: Albain KS
      – PersonEntity:
          Name:
            NameFull: Murthy RK
      – PersonEntity:
          Name:
            NameFull: Boughey JC
      – PersonEntity:
          Name:
            NameFull: Liu MC
      – PersonEntity:
          Name:
            NameFull: Haley BB
      – PersonEntity:
          Name:
            NameFull: Elias AD
      – PersonEntity:
          Name:
            NameFull: Clark AS
      – PersonEntity:
          Name:
            NameFull: Kemmer K
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Lang JE
      – PersonEntity:
          Name:
            NameFull: Han HS
      – PersonEntity:
          Name:
            NameFull: Edmiston K
      – PersonEntity:
          Name:
            NameFull: Viscusi RK
      – PersonEntity:
          Name:
            NameFull: Northfelt DW
      – PersonEntity:
          Name:
            NameFull: Khan QJ
      – PersonEntity:
          Name:
            NameFull: Leyland-Jones B
      – PersonEntity:
          Name:
            NameFull: Venters SJ
      – PersonEntity:
          Name:
            NameFull: Shad S
      – PersonEntity:
          Name:
            NameFull: Matthews JB
      – PersonEntity:
          Name:
            NameFull: Asare SM
      – PersonEntity:
          Name:
            NameFull: Buxton M
      – PersonEntity:
          Name:
            NameFull: Asare AL
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Schwab RB
      – PersonEntity:
          Name:
            NameFull: Helsten T
      – PersonEntity:
          Name:
            NameFull: Hylton NM
      – PersonEntity:
          Name:
            NameFull: van 't Veer L
      – PersonEntity:
          Name:
            NameFull: Perlmutter J
      – PersonEntity:
          Name:
            NameFull: DeMichele AM
      – PersonEntity:
          Name:
            NameFull: Yee D
      – PersonEntity:
          Name:
            NameFull: Berry DA
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2021 Nov 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1